Stock TRVX CIRCIO HOLDING ASA
Add to a list
To use this feature you must be a member
Log inSign up

All News Circio Holding ASA

Equities

TRVX

NO0013033795

Market Closed - Oslo Bors
Other stock markets
 08:15:00 08/05/2024 pm IST 		5-day change 1st Jan Change
2.23 NOK +1.36% Intraday chart for Circio Holding ASA -10.80% -69.03%
25/04 Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023 CI
17/04 Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
AQ
Circio : Annual Report 2023 Report
PU
Circio Holding ASA: Annual Report 2023
AQ
Circio Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Circio Holding ASA: Requested Conversion of Convertible Bonds
AQ
Circio Establishes In Vivo Proof-of-Concept for Circular RNA Platform
MT
Circio to Raise Up to NOK60 Million via Rights Issue
MT
Circio Terminates Cancer Vaccine License Deal in China
MT
Circio : Company update 17 April 2024
PU
Circio announces in vivo proof-of-concept for its circVec circular RNA platform technology and reinforced gene therapy focus
AQ
Circio Announces in Vivo Proof-Of-Concept for Its circVec circular RNA Platform Technology and Reinforced Gene Therapy Focus
CI
Transcript : Circio Holding ASA - Special Call
Circio announces intention to raise around NOK 50-60 million in Q2 2024 to extend cash runway to Q2 2025
AQ
Circio terminates TG01 cancer vaccine license option agreement with IOVaxis in China for non-payment
AQ
Circio Holding ASA Terminates TG01 Cancer Vaccine License Option Agreement with IOVaxis therapeutics in China for Non-Payment
CI
Circio Holding ASA: Requested Conversion of Convertible Bonds
PU
Circio Partner Exercises Option to License Cancer Vaccine in China
MT
Circio announces that partner IOVaxis Therapeutics has exercised the option for an exclusive license to mutant RAS cancer vaccine TG01 in China
AQ
Circio Holding ASA Announces Partner IOVaxis Therapeutics Exercises the Option for an Exclusive License to Mutant RAS Cancer Vaccine TG01 in China
CI
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TRVX Stock
  4. News Circio Holding ASA
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW